Literature DB >> 14993652

Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.

Stefanie Steidl1, Silke Schüle1, Michael D Mühlebach1, Jörn Stitz1, Klaus Boller1, Klaus Cichutek1, Matthias Schweizer1.   

Abstract

To achieve specific gene transfer into human CD4(+) cells, murine leukaemia virus (MLV)-based pseudotype vector particles were generated employing Env variants derived from human or simian immunodeficiency virus (HIV-1 or SIVagm). Here, we describe the generation of full-length onco/lentivirus hybrid genomes comprising components of MLV and HIV-1 or SIVagm, respectively, to assess the possibility of replication-competent hybrid virus formation. The env reading frame of an infectious molecular clone of MLV was replaced with the analogous coding regions of HIV-1 or SIVagm encompassing the env gene and accessory genes. Resulting MLV/HIV-1 or MLV/SIVagm hybrid genomes were transfected into 293T cells. Expression of viral proteins and budding of retroviral particles was shown by specific immunostaining and electron microscopy. The viral particles mediated CD4- and co-receptor-specific infection of human cells as demonstrated by PCR and immunostaining in the respective target cells. However, no productive infection resulting in the generation of infectious virus was detected in these cells. Thus, these onco/lentivirus hybrids, although able to initiate single-round infection, were not replication competent. Thus, MLV-based pseudotype vectors carrying Env variants of HIV-1 or SIVagm are not prone to form replication-competent retroviruses, suggesting a favourable safety profile for MLV-based CD4-specific pseudotype vectors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993652     DOI: 10.1099/vir.0.19479-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Authors:  Katharina M Uhlig; Stefan Schülke; Vivian A M Scheuplein; Anna H Malczyk; Johannes Reusch; Stefanie Kugelmann; Anke Muth; Vivian Koch; Stefan Hutzler; Bianca S Bodmer; Axel Schambach; Christian J Buchholz; Zoe Waibler; Stephan Scheurer; Michael D Mühlebach
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

2.  Murine leukemia virus (MLV) replication monitored with fluorescent proteins.

Authors:  Katja Sliva; Otto Erlwein; Alexandra Bittner; Barbara S Schnierle
Journal:  Virol J       Date:  2004-12-20       Impact factor: 4.099

3.  Intracellular assembly and budding of the Murine Leukemia Virus in infected cells.

Authors:  Laurent Houzet; Bernard Gay; Zakia Morichaud; Laurence Briant; Marylène Mougel
Journal:  Retrovirology       Date:  2006-02-10       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.